BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
BGM Group Ltd.
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jul 21, 2026
$8.97+0.32 (+3.70%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$266.46 (−96.74%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
BGM Group Ltd. grew revenue 51.1% to $37.92M over fiscal 2025. Free cash flow was -$3.94M, down 1395.3% from a year earlier.
Revenue
$37.92M
+51.1% vs. a year earlier
Operating income
-$12.58M
FY2025
Free cash flow
-$3.94M
-1395.3% vs. a year earlier
EPS, diluted
-$0.18
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Sep 30, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $37.92M
- Net income
- -$19.94M
- EPS, diluted
- -$0.18
- Free cash flow
- -$3.94M
Nine years at a glance
Fiscal years 2017 to 2025, USD
Revenue
$37.92M+51.1% YoY
Gross profit
$6.31M+53.4% YoY
Operating income
-$12.58M
Net income
-$19.94M
EPS, diluted
-$0.18
Free cash flow
-$3.94M-1395.3% YoY
Reported period